Excess Fatal Overdoses in the United States During the Covid-19 Pandemic by Geography and Substance Type
March 2020–August 2021
Datos Bibliográficos
Objectives. To assess heterogeneity in pandemic-period excess fatal overdoses in the United States, by location (state, county) and substance type. Methods. We used seasonal autoregressive integrated moving average (SARIMA) models to estimate counterfactual death counts in the scenario that no pandemic had occurred. Such estimates were subtracted from actual death counts to assess the magnitude of pandemic-period excess mortality between March 2020 and August 2021. Results. Nationwide, we estimated 25 668 (95% prediction interval [PI] = 2811, 48 524) excess overdose deaths. Specifically, 17 of 47 states and 197 of 592 counties analyzed had statistically significant excess overdose-related mortality. West Virginia, Louisiana, Tennessee, Kentucky, and New Mexico had the highest rates (20–37 per 100 000). Nationally, there were 5.7 (95% PI = 1.0, 10.4), 3.1 (95% PI = 2.1, 4.2), and 1.4 (95% PI = 0.5, 2.4) excess deaths per 100 000 involving synthetic opioids, psychostimulants, and alcohol, respectively. Conclusions. The steep increase in overdose-related mortality affected primarily the southern and western United States. We identified synthetic opioids and psychostimulants as the main contributors. Public Health Implications. Characterizing overdose-related excess mortality across locations and substance types is critical for optimal allocation of public health resources. ( Am J Public Health. 2024;114(6):599–609. https://doi.org/10.2105/AJPH.2024.307618 )
Confidence interval · Coronavirus disease 2019 (COVID-19) · Disease · Drug overdose · Environmental health · Excess mortality · Infectious disease (medical specialty) · Pandemic · Poison control · Population · Public health · COVID-19 and healthcare impacts · COVID-19 and Mental Health · Demography · Medicine · Opioid Use Disorder Treatment
Excess mortality
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019
Responding to the opioid crisis in North America and beyond
Emotional, Behavioral, and Psychological Impact of the Covid-19 Pandemic
The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the Covid-19 Pandemic—Perspectives of Necpam Members
The Impact of the Covid-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the Covid-19 global pandemic
The triple wave epidemic
Using Census Data to Understand County-Level Differences in Overall Drug Mortality and Opioid-Related Mortality by Opioid Type
Covid-19 and the Drug Overdose Crisis
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |